Showing results (281-290 of 427) with videos related to

Sort By:
Pageof 43
Haematologica|March 23, 2010
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phaseFrancesca Palandri, Fausto Castagnetti, Ilaria Iacobucci, et al.
European Journal of Haematology|May 25, 2010
Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletionEsther N Oliva, Maria Cuzzola, Francesco Nobile, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia: the GIMEMA Working Party on CMLFrancesca Palandri, Ilaria Iacobucci, Giovanni Martinelli, et al.
European Journal of Haematology|August 17, 2015
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phaseRoberto Latagliata, Chiara Montagna, Raffaele Porrini, et al.
Annals of Hematology|October 12, 2012
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemiaMario Tiribelli, Roberto Latagliata, Luigiana Luciano, et al.
Frontiers in Oncology|September 12, 2025
The prognostic value of health-related quality of life for early molecular response in patients with chronic myeloid leukemia: analysis of the GIMEMA-SUSTRENIM trialFabio Efficace, Laura Cannella, Isabella Capodanno, et al.
Annals of Hematology|April 20, 2023
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trialsLuigia Luciano, Roberto Latagliata, Gabriele Gugliotta, et al.
Hematological Oncology|July 13, 2016
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemiaMarta Chisini, Caterina Stefanizzi, Teresa Ceglie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2014
Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia: health-related quality-of-life outcomesFabio Efficace, Franco Mandelli, Giuseppe Avvisati, et al.
Haematologica|June 21, 2011
Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinibMassimo Breccia, Roberto Latagliata, Fabio Stagno, et al.
Pageof 43